Follows, Bruce published the artcileDiscovery of novel biaryl sulfonamide based Mcl-1 inhibitors, Safety of 4-Fluoro-2-methylbenzene-1-sulfonyl chloride, the main research area is Mcl 1 Bid sulfonamide crystal structure; BH3-mimetic; Inhibitors; Mcl-1; Myeloid cell leukemia-1; Small molecule.
Mcl-1 is an anti-apoptotic protein overexpressed in hematol. malignancies and several human solid tumors. Small mol. inhibition of Mcl-1 would offer an effective therapy to Mcl-1 mediated resistance. Subsequently, it has been the target of extensive research in the pharmaceutical industry. The discovery of a novel class of Mcl-1 small mol. inhibitors is described beginning with a simple biaryl sulfonamide hit derived from a high through put screen. A medicinal chem. effort aided by SBDD generated compounds capable of disrupting the Mcl-1/Bid protein-protein interaction in vitro. The crystal structure of the Mcl-1 bound ligand represents a unique binding mode to the BH3 binding pocket where binding affinity is achieved, in part, through a sulfonamide oxygen/Arg263 interaction. The work highlights the some of the key challenges in designing effective protein-protein inhibitors for the Bcl-2 class of proteins.
Bioorganic & Medicinal Chemistry Letters published new progress about Bid proteins Role: BSU (Biological Study, Unclassified), BIOL (Biological Study). 7079-48-3 belongs to class chlorides-buliding-blocks, name is 4-Fluoro-2-methylbenzene-1-sulfonyl chloride, and the molecular formula is C7H6ClFO2S, Safety of 4-Fluoro-2-methylbenzene-1-sulfonyl chloride.
Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics